Statement on EMTALA
A number of issues related to EMTALA have arisen with American Society of Plastic Surgeons (ASPS) members, and this statement is designed to briefly address some of the common problems that have been encountered.
Migraine Headache Surgery
This policy statement examines the safety and efficacy of peripheral nerve/trigger site surgery for refractory chronic migraine headache (MH).
This policy statement details recommendations for the safety and efficacy of a single surgeon performing concurrent/overlapping surgery.
Breast Implant Specimens and Pathology
This position statement details recommendations for what samples to send for pathology examination in the event of suspicious or confirmed cases of Breast Implant-Associated ALCL.
Administration of Botulinum Toxin Nueromodulators
Updated and Reaffirmed 2016
The policy statement on Administration of Botulinum Toxin Nueromodulators addresses complications, patient selection, provider qualification and risk management.
Breast Augmentation in Teenagers
This policy statement talks about patient selection, informed consent and provider qualification.
Stem Cells and Fat Grafting
The following position statement addresses the concerns emerging from claims relating to stem cell therapies in aesthetic plastic surgery.